DEC 03, 2022 8:30 AM PST

Promising Epilepsy Treatment Suppresses Neuroinflammation

WRITTEN BY: Kerry Charron

A team of City University of Hong Kong (CityU) neuroscientists recently identified and developed a new drug candidate for treating temporal lobe epilepsy (TLE) by suppressing neuroinflammation called D4. The study and its promising results were published in Proceedings of the National Academy of Sciences. TLE is one of the most common types of epilepsy and about one-third of TLE patients have a drug resistant form of the disorder, so drug discovery for this patient population is critical. 

The CityU research team adopted the pilocarpine model of epilepsy in mice in order to produce phenotypes that resemble human TLE. Pilocarpine was injected into mice to induce seizures. One oral dose of D4 before inducing seizures effectively reduced neuroinflammation. It also altered synaptic inhibition, which increased the animal’s survival rate. A single dose of D4 after an induced seizure also effectively limited the activation of astrocytes and microglia. This finding suggests D4 strongly alleviates neuroinflammation and has a long-term effect.  

Most anti-epileptic drugs that are currently available target neurons and synapses in the brain, but this treatment does not always address the pathology of neuroinflammation. Abnormal functioning of reactive glial cells results in neuroinflammation known as astrocytes and microglia. The study suggested that D4 significantly suppresses the TLE-induced neuroinflammation, curbs seizures, and increases survival rate by blocking connexin hemichannels. D4 targets a new class of ion channels, the connexin hemichannels in the glial cells. Glial cells include astrocytes and microglia and are important for modulating neurotransmission. Excessive glutamate and other molecules can leak out from reactive glia via hemichannels to the extracellular environment, altering synapses, enhancing neuroinflammation and exacerbating seizures. By specifically blocking connexin hemichannels using D4, the researchers can specifically target neuroinflammation caused by astrocytes and microglia.

Sources: CityU research, Eureka News Alert, PNAS

 

About the Author
Bachelor's (BA/BS/Other)
Kerry Charron writes about medical cannabis research. She has experience working in a Florida cultivation center and has participated in advocacy efforts for medical cannabis.
You May Also Like
DEC 01, 2022
Cannabis Sciences
The first medical marijuana research bill
The first medical marijuana research bill
The first medical marijuana research bill is coming. Here's the details, and what it could mean for the science communit ...
DEC 04, 2022
Neuroscience
International Study Highlights the Link Between Sleep Supporting Methods and Child Development
International Study Highlights the Link Between Sleep Supporting Methods and Child Development
A new study published in Frontiers in Psychology examined the effect of different parental sleep-supporting techniques o ...
DEC 31, 2022
Neuroscience
A New Lead on Premature Brain Aging
A New Lead on Premature Brain Aging
A new study published in Aging showed that white matter hyperintensities (WMHs) are independently associated with premat ...
JAN 23, 2023
Health & Medicine
The Brain's Zone of Uncertainty and Memory Formation
The Brain's Zone of Uncertainty and Memory Formation
Researchers at the University of Freiburg Medical School and the Max Planck Institute for Brain Research have discovered ...
JAN 24, 2023
Neuroscience
Poor Marital Communication Linked to Inflammation and Slower Healing Wounds
Poor Marital Communication Linked to Inflammation and Slower Healing Wounds
Negative communication patterns between spouses are linked to higher inflammation and slower healing of physical wounds ...
JAN 28, 2023
Neuroscience
The Physical Activities of the Cognitively Gifted
The Physical Activities of the Cognitively Gifted
People in the higher two quartiles in cognition practiced more moderate, vigorous physical activity and sitting
Loading Comments...